Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
acetylcholine receptor
acetylcholine receptor antibody
acetylcholinesterase
activities of daily living
advance directives
advances in neurology
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
alpha methyltyrosine
Alzheimer's disease
Alzheimer's disease, behavioral symptoms
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amantadine
amitriptyline
amnesia
amphetamines
amyloid beta protein
amyloid imaging
analgesic
anesthesia, general
anesthesia, local
anorexia
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antioxidant
antistriational muscle antibody
anxiety
apnea
apolipoprotein E
apomorphine
apraxia
apraxia, constructional
arthralgia
arthrogryposis multiplex
ataxia
ataxia, hereditary
atropine
atypical
autoimmune disease
autonomic dysfunction
azathioprine
baclofen
behavior
behavior, combative
behavioral disorder
Bell's phenomenon
benzodiazepine
beta adrenergic blocker
biological warfare
blepharospasm
Brueghel's syndrome
bulbar palsy
caloric testing
caloric testing, unconscious patient
camphor
carbamazepine
caregiver
CAT scan, emission
CAT scan, emission, abnormal
cerebellar atrophy, primary
cerebrospinal fluid, elevated protein of
chemical weapons
chlorambucil
choline chloride
cholinergic crisis
cholinergic drug
chorea
chronic fatigue syndrome
clonazepam
clozapine
clubfoot as related to neurologic disease
cocaine
cognition
Collier's sign
coma
complications
conflict of interest
confusion
congenital myasthenic syndromes
consanguinity
contrast agents, neurotoxicity of
controversies in neurology
cost
cost effectiveness
critical care unit
cyclophosphamide
cyclosporine
cytokines
deanol
DEET
delay in diagnosis
delirium
delusion
dementia
dementia, cerebrovascular disease causing
dementia, diagnostic classification
dementia, diagnostic evaluation of
dementia, prevention of
dementia, treatment of
dementia, unknown etiology
deprenyl
depression
developmental retardation
diarrhea
differential diagnosis
dilantin
diplopia
donepezil
dopamine
dopamine agonist
dopamine antagonist
driving
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
drug withdrawal
dysnomia
dystonia
dystonia, drug induced
dystonia, face
dystonic reaction, acute
eating disorder
echolalia
efficacy
electroconvulsive therapy
electromyogram
electromyogram, decremental response
emergencies, neurologic
enzyme inhibition
ephedrine
ergonovine
evidence-based research
executive dysfunction
exercise
exome sequencing
eye closure
eye, pain in
facial hallucinations
facial weakness
falling
fatigue
felbamate
folic acid
Friedreich's ataxia
galantamine
gammaglobulin therapy, intravenous
gene
gene mutation
genetic neurologic disorders
Gilles de la Tourette syndrome
ginkgo biloba
ginseng
Gulf War syndrome
hallucination
haloperidol
headache
hepatitis
heralding manifestation
herbs
high arched palate
hoarding
Huntington's chorea
hyperbaric oxygen
hyperbaric treatment
iatrogenic neurologic disorders
immunologic disease
immunosuppressive agents
inappropriate behavior
insect repellent
insecticides
insomnia
intellectual deficit
interferon
intestinal pseudoobstruction
irritability
lacrimation
lecithin
level of consciousness, decreased
Lewy body disease, diffuse
lid abnormalities
lid closure, weakness of
lid twitch
lidocaine
lithium
liver disease
liver function enzymes
malabsorption
malformation, CNS, congenital
managed care
maprotiline
mediastinum, mass of
memantine
memory
memory, defect of recent
memory, disorder, treatment of
memory, impairment of
memory, impairment of, subjective
mestinon
metrifonate
microcephaly
mild cognitive impairment
Mini Mental Status Examination
miosis
misdiagnosis
mongolism
mortality
movement disorder
movement disorder, drug induced
MRI, abnormal
multiple sclerosis
muscle biopsy
muscle pain
muscle weakness
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, anticholinesterase malabsorption in
myasthenia gravis, anticholinesterase serum levels in
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, differential diagnosis
myasthenia gravis, drug induced
myasthenia gravis, etiology of
myasthenia gravis, infantile and juvenile
myasthenia gravis, misdiagnosis of
myasthenia gravis, neuromuscular junction in
myasthenia gravis, ocular
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, remission of
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, unmasked
myasthenic crisis
mycophenolate
nalidixic acid
narcotic analgesics
nasal speech
nausea and vomiting
nerve agents
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuromuscular blockade
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuroophthalmology
neuropathology
neuropathy
neuropathy, toxic
neurotoxic
neurotoxin
NMDA antagonists
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
ocular motility, disorders of
oculocephalic reflex
olanzapine
old age, neurology of
opened mouth
ophthalmoplegia
ophthalmoplegia, total
pain, abdominal
papaverine
paranoia
Parkinson disease
Parkinson disease, dementia with
Parkinson disease, nonmotor problems of
Parkinsonism syndrome
patient information and support
penicillamine
penicillin
personality change
phencyclidine poisoning
phenobarbital
phenothiazine
phenylpropanolamine
physostigmine
pimozide
Pisa syndrome
Pittsburgh Compound B
plasmapheresis
poison, neurologic problems with
poison, organophosphate
polyneuropathy
postural abnormality
practice guidelines
pregnancy, neurologic complications in
premarin
prevention of neurologic disorders
prognosis
propranolol
prosopometamorphopsia
prostigmine
pseudointernuclear ophthalmoplegia
psychiatric disorder
psychiatric problems in neurologic disorders
psychological testing
psychomotor retardation
psychosis
psychotic behavior
ptosis
ptosis, bilateral
pupil, dilated, bilateral
quality of life
quetiapine
quinine
radiotracer imaging
repetitive nerve stimulation
repetitive questioning
reserpine and reserpine like drugs
respiratory failure
respiratory paralysis, pharmacologic
review article
Reye's syndrome
rhinorrhea
risk factors
risk-benefit assessment
risperidone
rivastigmine
rummaging
saccadic eye movements
saccadic eye movements, abnormal
safety
salivation, excessive
Sarin
seizure
seizure, drug-induced
selective serotonin reuptake inhibitors
senile plaques
seronegative
serum alanine aminotransferase
shadowing
single photon emission computed tomography
single-fiber electromyography
sleep
sleep pathology and physiology
snake bite
Soman
spinocerebellar ataxia type 1
spinocerebellar degeneration
stereotyped behavior
steroid
steroid therapy, CNS treatment and complications with
sumatriptan
sympathomimetic drugs
Tabun
tachycardia
tachypnea
tardive dyskinesia
tardive dyskinesia, treatment of
tensilon
tensilon test, false negative
tensilon test, false positive
tensilon test, paradoxical
tetrabenazine
tetrahydroaminoacridine
thymectomy
thymoma
thymus and neuromuscular function
toxins, nervous system
treatment of neurologic disorder
treatment, non-pharmacologic
upgaze, paralysis of
vaccination, neurologic complications with
visuospatial disturbance
vitamin E
vitamin K
voice, abnormality of
VX
wandering
war
weakness
weakness, fatiguable
weakness, generalized
weakness, proximal
weight loss
white matter disease
workup
Showing articles 0 to 50 of 131 Next >>

The Effects of Long-Term Medication Use in Alzheimer Disease
Neurol 96:e2247-e2250, Karceski, S., 2021

Diagnosis and Management of Dementia
JAMA 322:1589-1599, Arvanitakis, Z.,et al, 2019

A Child with Arthrogryposis
Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018

International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016

CBRNE - Nerve Agents, V-series - Ve, Vg, Vm, Vx
emedicine Feb, Keyes, D.C. & Caneva, D.C., 2015

Efficacy and Safety of Cholinesterase Inhibitors and Memantine in Cognitive Impairment in Parkinsons Disease, Parkinsons Disease Dementia, and Dementia with Lewy Bodies: Systematic Review with Meta-Analysis and Trial Sequential Analysis
JNNP 86:135-143, Wang, H.F.,et al, 2015

Assessment and Management of Behavioral and Psychological Symptoms of Dementia
BMJ 350:h369, Kales, H.C.,et al, 2015

Degenerative Diseases of the Nervous System, Alzheimer Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1063, Ropper, A.H.,et al, 2014

Prosopometamorphopsia and Facial Hallucinations
Lancet 384:1998, Blom, J.D.,et al, 2014

Donepezil and Memantine for Moderate-to Severe Alzheimers Disease
NEJM 366:893-903,957, Howard,R.,et al, 2012

Myasthenia Gravis
BMJ 345:e8497, Spillane, J.,et al, 2012

Effectiveness of Adding Memantine to an Alzheimer Dementia Treatment Regimen Which Already Includes Stable Donepezil Therapy: A Critically Appraised Topic
The Neurologist 17:121-123, Riordan,K.C.,et al, 2011

Early Alzheimers Disease
NEJM 362:2194-2201, Mayeux,R., 2010

Effects of a Central Cholinesterase Inhibitor on Reducing Falls in Parkinson Disease
Neurol 75:1263-1269, Chung,K.A.,et al, 2010

Alzheimers Disease
BMJ 338:467-471, Burns,A. &Iliffe,S., 2009

Donepezil Treatment of Patients with MCI: A 48-Week Randomized, Placebo-Controlled Trial
Neurol 72:1555-1561, Doody,R.S.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Safety and Efficacy of Galantamine in Subjects with Mild Cognitive Impairment
Neurol 70:2024-2035, Winblad,B.,et al, 2008

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008

Treatment of Ocular Symptoms in Myasthenia Gravis
Neurol 71:1335-1341, Bhanushali,M.J.,et al, 2008

Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007

Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007

Galantamine Treatment of Vascular Dementia: A Randomized Trial
Neuorl 69:448-458, Auchus,A.P.,et al, 2007

Donepezil Preserves Cognition and Global Function in Patients With Severe Alzheimer Disease
Neurol 69:459-469, Black,S.E.,et al, 2007

Donepezil for the Treatment of Agitation in Alzheimers Disease
NEJM 357:1382-1392,1441, Howard,R.J.,et al, 2007

Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy
Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007

Practice Parameter: Evaluation and Treatment of Depression, Psychosis, and Dementia in Parkinson Disease (An Evidence-Based Review)
Neurol 66:996-1002, Miyasaki,J.M.,et al, 2006

Donepezil in Patients with Severe Alzheimers Disease: Double-Blind, Parallel-Group, Placebo-Controlled Study
Lancet 367:1057-1065,1031, Winblad,B.,et al, 2006

Behavioral Effects of Memantine in Alzheimer Disease Patients Receiving Donepezil Treatment
Neurol 67:57-63, Cummings,J.L.,et al, 2006

Effect of Donepezil on Motor and Cognitive Function in Huntington Disease
Neurol 67:1268-1271, Cubo,E.,et al, 2006

Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005

Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005

Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005

Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005

Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004

Size of the Treatment Effect on Cognition of Cholinesterase Inhibition in Alzheimer's Disease
JNNP 75:677-685, Rockwood,K., 2004

Alzheimer's Disease
NEJM 351:56-67, Cummings,J.L, 2004

The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004

Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004

Management of Myasthenia Gravis
Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004

Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004

Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004

Donepezil Improved Memory in Multiple Sclerosis in a Randomized Clinical Trial
Neurol 63:1579-1585, Krupp,L.B.,et al, 2004

Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric symptoms and Functional Impairment in Alzheimer Disease
JAMA 289:210-216, Trinh,N.,et al, 2003

Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003



Showing articles 0 to 50 of 131 Next >>